S. Benenati

发表

Very Short vs. Long Dual Antiplatelet Therapy after Second Generation Drug-eluting Stents in 35,785 Patients undergoing Percutaneous Coronary Interventions: a Meta-analysis of Randomised Controlled Trials.

I. Porto, F. Crea, F. Andreotti, 2020, European heart journal. Cardiovascular pharmacotherapy.

Cardiac CT perfusion and FFRCTA: pathophysiological features in ischemic heart disease.

Filippo Cademartiri, A. Sakellarios, I. Porto, 2020, Cardiovascular diagnosis and therapy.

Early infections after successful transcatheter aortic valve replacement are associated with increased short- and long-term mortality: A single-center study.

I. Porto, M. Bassetti, M. Vercellino, 2021, International journal of cardiology.

Mechanical circulatory support in patients with cardiogenic shock not secondary to cardiotomy: a network meta-analysis

I. Porto, G. Crimi, S. Benenati, 2021, Heart Failure Reviews.

What are the causes of a suboptimal FFR after coronary stent deployment? Insights from a consecutive series using OCT imaging.

K. Channon, A. Lucking, J. Langrish, 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Efficacy and safety of dual-pathway inhibition in patients with cardiovascular disease: a meta-analysis of 49 802 patients from 7 randomized trials

F. Crea, D. Angiolillo, D. Capodanno, 2021, European Heart Journal - Cardiovascular Pharmacotherapy.

Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis

I. Porto, D. Angiolillo, D. Capodanno, 2021, The Lancet.

The Incidence and Impact of In-Hospital Bleeding in Patients with Acute Coronary Syndrome during the COVID-19 Pandemic

S. Nava, V. Pasceri, A. Colombo, 2022, Journal of clinical medicine.

Direct oral anticoagulants versus vitamin-K antagonists in patients with left ventricular thrombus: A systematic review and meta-analysis.

G. Masoero, S. Benenati, P. Ameri, 2022, Vascular pharmacology.

Atrial fibrillation and Alzheimer’s disease: A conundrum

I. Porto, S. Benenati, R. Della Bona, 2020, European journal of clinical investigation.

Sacubitril/valsartan in real‐life European patients with heart failure and reduced ejection fraction: a systematic review and meta‐analysis

M. Sormani, M. Metra, M. Senni, 2021, ESC heart failure.

Mechanical Unloading of the Left Ventricle before Coronary Reperfusion in Preclinical Models of Myocardial Infarction without Cardiogenic Shock: A Meta-Analysis

I. Porto, M. Vercellino, M. Balbi, 2022, Journal of clinical medicine.

The impact of blood pressure variability on coronary arterial lumen dimensions as assessed by optical coherence tomography in patients with ST-elevation myocardial infarction.

K. Channon, H. Garcia-Garcia, J. Dijkstra, 2019, Cardiovascular revascularization medicine : including molecular interventions.

Efficacy and safety of dual pathway inhibition in patients with cardiovascular disease: a systematic review and Meta-analysis.

F. Crea, D. Angiolillo, D. Capodanno, 2021, European heart journal. Cardiovascular pharmacotherapy.

BMI and acute kidney injury post transcatheter aortic valve replacement: unveiling the obesity paradox

I. Porto, M. Vercellino, M. Balbi, 2021, Journal of cardiovascular medicine.

Rescue aortic balloon valvuloplasty during procedural cardiac arrest while treating critical left main stem stenosis: a case report

A. Banning, S. Benenati, G. D. De Maria, 2020, European heart journal. Case reports.

Revascularization strategies versus optimal medical therapy in chronic coronary syndrome: A network meta-analysis.

R. de Caterina, F. Burzotta, C. Trani, 2022, International journal of cardiology.

Dual antiplatelet therapy in the contemporary drug-eluting stents era: from vulnerable stents to vulnerable patients

I. Porto, S. Benenati, 2022, Journal of Thrombosis and Thrombolysis.

Impact of coronary stenting on top of medical therapy and of inclusion of periprocedural infarctions on hard composite endpoints in patients with chronic coronary syndromes: a meta-analysis of randomized controlled trials.

A. M. Leone, C. Trani, G. Niccoli, 2021, Minerva cardiology and angiology.

Coronary Atherosclerotic Phenotype and Plaque Healing in Patients With Recurrent Acute Coronary Syndromes Compared With Patients With Long-term Clinical Stability: An In Vivo Optical Coherence Tomography Study

V. Fuster, F. Burzotta, C. Trani, 2019, JAMA cardiology.

Invasive "in the cath-lab" assessment of myocardial ischemia in patients with coronary artery disease: When does the gold standard not apply?

I. Porto, A. Banning, S. Benenati, 2018, Cardiovascular revascularization medicine : including molecular interventions.

Tailoring risk prediction at the patient level: future perspectives in cardiovascular medicine.

S. Benenati, M. Canepa, 2020, International journal of cardiology.

The role of invasive and non-invasive imaging technologies and calcium modification therapies in the evaluation and management of coronary artery calcifications

A. Banning, R. Kotronias, S. Benenati, 2023, Frontiers in Cardiovascular Medicine.

Yield of bone scintigraphy screening for transthyretin‐related cardiac amyloidosis in different conditions: Methodological issues and clinical implications

C. Autore, P. Vianello, S. Benenati, 2021, European journal of clinical investigation.

Duration of dual antiplatelet therapy and subsequent monotherapy type in patients undergoing drug eluting stent implantation: a network Meta-analysis.

I. Porto, F. Crea, G. Crimi, 2020, European heart journal. Cardiovascular pharmacotherapy.

Periprocedural antithrombotic strategies in acute coronary syndromes undergoing percutaneous coronary intervention: Have we discarded bivalirudin too soon?

R. Kharbanda, A. Banning, R. Kotronias, 2023, Cardiovascular revascularization medicine : including molecular interventions.

Long-Term Outcomes of Transvenous Lead Extraction: A Comparison in Patients with or without Infection from the Italian Region with the Oldest Population

P. Di Donna, M. Bassetti, A. Vena, 2023, Journal of Clinical Medicine.

Impact of bioprosthetic valve type on peri-procedural myocardial injury and mortality after transcatheter aortic valve replacement

I. Porto, M. Vercellino, M. Balbi, 2021, Heart and Vessels.

Coronary physiology thresholds associated with microvascular obstruction in myocardial infarction

A. Palmisano, S. Pica, G. Crimi, 2023, Heart.

Coronary Spasm Testing with Acetylcholine: A Powerful Tool for a Personalized Therapy of Coronary Vasomotor Disorders

G. Niccoli, L. Vignali, S. Benenati, 2024, Life.

Why percutaneous revascularisation might not reduce the risk of myocardial infarction and mortality in patients with stable CAD?

R. Kotronias, S. Benenati, G. D. De Maria, 2023, Open Heart.

Comparison of Mid-Term Prognosis in Intermediate-to-Low-Risk Contemporary Population with Guidelines-Oriented Age Cutoff

A. Regueiro, A. Mangieri, F. Gallo, 2024, Journal of cardiovascular development and disease.

Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction.

F. Burzotta, G. Niccoli, D. Angiolillo, 2023, Nature reviews. Cardiology.

Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials.

D. Angiolillo, J. T. ten Berg, D. Sibbing, 2021, European heart journal.